We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA next month will hold a public meeting to review the status of the Study
Data Tabulation Model (SDTM) for clinical trial data submissions and to discuss
the agency's experience with and plans for the proposed standard format, which
was developed by the Clinical Data Interchange Standards Consortium (CDISC).
The Pharmaceutical Research Institute has received nearly $3 million in donated
laboratory equipment since establishing its headquarters at the Albany College
of Pharmacy in 2003.
A California company said it has expanded its collaboration with the University
of Miami and Stanford University to study genetic biomarkers associated with
treatment response and survival in the most common form of non-Hodgkin's lymphoma.
Geron has announced a worldwide license agreement between Geron and Cambrex
Bio Science Walkersville, under which the Cambrex subsidiary will develop and
distribute cell lines that have been immortalized using Geron's proprietary
telomerase technology.
Sanofi-aventis has announced that, following a review of the Vascular Endothelial
Growth Factor (VEGF) Trap program, it has reaffirmed its commitment to develop
the VEGF Trap in oncology in collaboration with Regeneron Pharmaceuticals.
GlaxoSmithkline Biologicals, the vaccine business of pharma major GlaxoSmithKline
(GSK), will make India a global hub for clinical research and development.
Sirna Therapeutics and Targeted Genetics have established a collaboration to
develop a novel therapy for the treatment of Huntington's Disease (HD), an incurable
neurodegenerative disorder.